Tae-Hyun Kim Selected Research

Glucose (Dextrose)

1/2018	Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis.
1/2011	Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db Mice.
1/2010	Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.
4/2005	Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae-Hyun Kim Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 05/2006
6	Inflammation (Inflammations) 01/2021 - 12/2002
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2014 - 02/2004
4	Type 2 Diabetes Mellitus (MODY) 05/2013 - 04/2005
4	Neoplasm Metastasis (Metastasis) 11/2010 - 04/2006
3	Status Epilepticus (Complex Partial Status Epilepticus) 05/2022 - 02/2021
3	Epilepsy (Aura) 04/2022 - 04/2021
3	Seizures (Absence Seizure) 04/2021 - 08/2020
3	Phototoxic Dermatitis (Phototoxicity) 10/2016 - 11/2013
3	Myoma 07/2015 - 07/2014
2	Necrosis 02/2021 - 06/2003
2	Osteoporosis 01/2021 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2020 - 02/2004
2	Melanoma (Melanoma, Malignant) 01/2020 - 08/2009
2	Wounds and Injuries (Trauma) 01/2020 - 01/2013
2	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2009
2	Dehydration (Water Stress) 01/2018 - 01/2016
2	Infections 01/2018 - 05/2011
2	Obesity 01/2018 - 03/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 05/2013
2	Insulin Resistance 01/2018 - 01/2012
2	Postoperative Pain 11/2015 - 07/2014
2	Adenomyosis 07/2015 - 04/2015
2	Glioma (Gliomas) 04/2006 - 03/2006
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021
1	Drug Resistant Epilepsy 08/2021
1	Peritonitis 01/2021
1	Bone Resorption 01/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021
1	Hernia (Hernias) 10/2020
1	Incisional Hernia 10/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Body Weight Changes 01/2020
1	Pathologic Constriction (Stenosis) 01/2020

Drug/Important Bio-Agent (IBA)

9	Pharmaceutical PreparationsIBA 11/2021 - 03/2007
5	LigandsIBA 10/2016 - 06/2003
4	AcidsIBA 05/2022 - 08/2020
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2005
3	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
3	GoldIBA 10/2016 - 11/2013
3	Photosensitizing Agents (Photosensitizers)IBA 10/2016 - 09/2013
3	TrypsinIBA 06/2003 - 12/2002
2	bardoxolone methylIBA 05/2022 - 04/2022
2	AMPA Receptors (AMPA Receptor)IBA 08/2021 - 04/2021
2	perampanelIBA 08/2021 - 04/2021
2	GYKI 52466IBA 08/2021 - 04/2021
2	Glutamic Acid (Glutamate)FDA Link 04/2021 - 08/2020
2	Caspase 3 (Caspase-3)IBA 02/2021 - 01/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2021 - 01/2020
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 01/2017
2	Insulin (Novolin)FDA Link 01/2018 - 01/2012
2	poly(ethylene glycol)-poly(aspartate hydrazide)IBA 10/2016 - 11/2013
2	hydroxide ionIBA 01/2016 - 01/2014
2	Biological ProductsIBA 09/2015 - 05/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2015 - 11/2013
2	EnzymesIBA 05/2011 - 01/2011
2	Proteinase-Activated ReceptorsIBA 12/2003 - 06/2003
2	Tryptases (Tryptase)IBA 07/2003 - 12/2002
2	PAR-2 ReceptorIBA 07/2003 - 12/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2003 - 12/2002
1	EstersIBA 05/2022
1	Dynamins (Dynamin)IBA 04/2022
1	Serine (L-Serine)FDA Link 04/2022
1	Glutathione (Reduced Glutathione)IBA 04/2022
1	Pilocarpine (Ocusert)FDA LinkGeneric 04/2021
1	ParvalbuminsIBA 02/2021
1	HMGB1 Protein (HMG1)IBA 02/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	StrontiumIBA 01/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2021
1	Actins (F Actin)IBA 01/2021
1	Neurofibromin 2 (Merlin)IBA 01/2021
1	tartaric acid (tartrate)FDA Link 01/2021
1	S 10 (S-10)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Ligand-Gated Ion ChannelsIBA 08/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	1-methylnaphthaleneIBA 01/2020
1	Axitinib (AG 013736)IBA 01/2020
1	Biopolymers (Biopolymer)IBA 01/2020
1	PlatinumIBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2021 - 04/2006
5	Radiotherapy 12/2008 - 02/2004
4	Precision Medicine 01/2017 - 11/2013
4	Photochemotherapy (Photodynamic Therapy) 10/2016 - 09/2013
3	Hysterectomy 07/2015 - 10/2014
2	Suture Techniques 10/2020 - 07/2014
2	Proton Therapy 01/2020 - 09/2008
2	Fluid Therapy (Oral Rehydration Therapy) 01/2018 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 12/2008
2	Lasers (Laser) 10/2016 - 07/2015
2	Operative Time 11/2015 - 07/2014
2	Length of Stay 11/2015 - 07/2014
1	Sutures (Suture) 10/2020
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 10/2020